Navigation Links
Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
Date:8/19/2007

dy will be included in the approved prescribing information in the U.S. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk Factors" section of Pharmion's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2007, its Annual Report on Form 10-K for the year ended December 31, 2006 and in Pharmion's other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made and Pharmion undertakes no obligation to update these forward-looking statements, even if new information becomes available in the future.

The scientific information discussed in this press release is preliminary and investigative. Vidaza has not yet been approved by the EMEA in the EU and the results described in this press release have not been approved for inclusion in the prescribing information for Vidaza by the FDA in the U.S. or any other regulatory authority.


'/>"/>
SOURCE Pharmion Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
2. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015 ... announced the addition of the "Arthroscopy ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose ... size the world market for Arthroscopy Devices. ... trends impacting the market for these products. ...
(Date:5/21/2015)... NEW YORK , 21. Mai ... (NASDAQ: DPRX ), ein Unternehmen ... sich auf die Entwicklung und Vermarktung ... Forschungszusammenarbeit konzentriert, kündigte heute eine wissenschaftliche ... der Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 ...
(Date:5/21/2015)... , May 21, 2015 Research and Markets ... addition of the "Global Next Generation Sequencing ... The global next generation sequencing market to ... period 2014-2019 This report covers the ... global next generation sequencing market for the period ...
Breaking Medicine Technology:Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7Global Next Generation Sequencing Market 2015-2019 2
... Researchers,testing a vaccine based on the live bacteria Listeria, ... safe. The Lovaxin C vaccine being,developed by Advaxis Inc. ... and head and neck cancers that result from the ... vaccine had been,treated in humans. "Our long held ...
... November 2 at the American Society of Nephrology ... ... Inc. (Nasdaq: EXEL ) announced that a recently completed phase 2,trial ... placebo in patients with proteinuria associated with diabetic,nephropathy. Exelixis is continuing to ...
Cached Medicine Technology:New Study Shows Listeria Vaccine for Cervical Cancer Found Safe 2Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 2Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 3Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 4
(Date:5/22/2015)... According to Berks and Beyond , Pennsylvania has ... almost 2,500 confirmed drug deaths, as reported on May 7th. ... deaths stemming from legal and illegal drug use in 2014. ... day to fatal overdoses or other drug related deaths. The ... the most rife with drug related deaths. The city, along ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Medivo, Inc., a ... “Positivity Rates and Genotype Results in ‘Baby Boomers’ Screened for ... a Nationwide Lab Test Database” at Digestive Disease Week, May ... Clinical Affairs and Analytics team members Carol Smyth, MB; Jason ... Andrea Parker, MSI, along with Nancy Reau, MD from the ...
(Date:5/22/2015)... Wimbledon Health Partners, the leading on-site diagnostic ... NCV testing , is proud to announce the ... National athlete, to the Wimbledon Athletics division. , ... of testing and information it provides to be extremely ... this way they can focus on the task at ...
(Date:5/22/2015)... Phoenix, AZ (PRWEB) May 22, 2015 ... Special Olympics, Parker and Sons is offering to donate ... for installing an AC unit or water softening system. ... their behalf; Parker and Sons gets business; and the ... , The Special Olympics helps over 4.4 million ...
(Date:5/22/2015)... IL (PRWEB) May 22, 2015 Co founders ... purpose is to allow general dentists to immediately deliver fully ... is based on that of the medical surgeon. , ... six main roadblocks preventing general dentists from placing dental implants. ... the necessary steps to introduce the surgical placement of dental ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2
... Wake Forest University School of Medicine have destroyed prostate cancer ... tubes and then superheating the tubes with a brief zap ... carbon nanotubes (MWCNTs) to treat human prostate cancer tumors in ... healed within days. "That we could eradicate the tumor ...
... , , , ... while effectively managing costs , , PLYMOUTH ... used to describe a range of medical supplies, such as pricey ... hospital,s total supply costs. With operating costs increasing and margins ...
... , WASHINGTON, Aug. 19 Following is ... , The "Bulletin," which is free of charge ... the latest issues and news affecting people with disabilities. To subscribe ... "Online mailing list archives," select "NCD-NEWS-L," click on "Join or leave ...
... ... Getting the Sleep They Need, , ... Los Angeles, CA (PRWEB) August 19, 2009 -- Nearly 20 million Americans suffer from ... and weight gain, heart attack, stroke, high blood pressure, asthma and depression. Sleep apnea has ...
... , , ... of healthcare providers are using the OnDemand AP(SM) solution ... invoice processing costs and cycle time, and improving internal controls and ... of their invoices electronically, even from suppliers who do not currently ...
... KENNETT SQUARE, Pa., Aug. 19 Genesis ... companies, today announced that 16 of its Centers have been ... Award presented by the American Health Care Association and National ... assisted living centers from across the nation applied for the ...
Cached Medicine News:Health News:DNA-coated nanotubes help kill tumors without harm to surrounding tissue 2Health News:Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 2Health News:Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 3Health News:National Council on Disability Monthly Bulletin for August 2009 2Health News:National Council on Disability Monthly Bulletin for August 2009 3Health News:National Council on Disability Monthly Bulletin for August 2009 4Health News:National Council on Disability Monthly Bulletin for August 2009 5Health News:National Council on Disability Monthly Bulletin for August 2009 6Health News:National Council on Disability Monthly Bulletin for August 2009 7Health News:How Well Do You Sleep At Night? Visit The New Online Aviisha Medical Wellness Institute To Find Out 2Health News:How Well Do You Sleep At Night? Visit The New Online Aviisha Medical Wellness Institute To Find Out 3Health News:Healthcare Providers Employ GHX OnDemand AP(SM) Solution to Automate and Streamline Invoice-to-Payment Process 2Health News:Healthcare Providers Employ GHX OnDemand AP(SM) Solution to Automate and Streamline Invoice-to-Payment Process 3Health News:Healthcare Providers Employ GHX OnDemand AP(SM) Solution to Automate and Streamline Invoice-to-Payment Process 4Health News:Sixteen Genesis HealthCare Centers Receive Prestigious Award for Continuous Quality Improvement in Long Term Care 2Health News:Sixteen Genesis HealthCare Centers Receive Prestigious Award for Continuous Quality Improvement in Long Term Care 3
... advanced multi-functional microplate detection system, ,offers ... without compromising flexibility. ,The Ultra ... the Ultra instrument platform. New features ... to the flexibility of the existing ...
... a fully automated microplate based multi-detection ... principles:, , Fluorescence Polarization , ... , High-Performance Luminescence (flash and glow) ... is designed for the widest possible ...
... a flexible multifunction plate reader that offers ... fluorescence intensity, time-resolved fluorescence, high-perfomance luminescence and ... with injectors that deliver reagent at the ... cell assays can be performed easily and ...
... High sensitivity and fast ... eight different radiometric and ... system with true high ... assays, by exploiting the ...
Medicine Products: